A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks

NCT00634790 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

49

Enrollment

INDUSTRY

Sponsor class

Stopped Please see Detailed Description for termination reason.

Conditions

Panic Disorder

Interventions

DRUG: alprazolam XR

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.